123 related articles for article (PubMed ID: 17580254)
1. Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis.
Battiwalla M; Wu Y; Bajwa RP; Radovic M; Almyroudis NG; Segal BH; Wallace PK; Nakamura R; Padmanabhan S; Hahn T; McCarthy PL
Biol Blood Marrow Transplant; 2007 Jul; 13(7):765-70. PubMed ID: 17580254
[TBL] [Abstract][Full Text] [Related]
2. The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation.
Giebel S; Maccario R; Lilleri D; Zecca M; Avanzini MA; Marconi M; Di Cesare Merlone A; Campanini G; Montagna D; Travaglino P; Gentile R; Telli S; Pagliara D; Holowiecki J; Locatelli F
Bone Marrow Transplant; 2005 Sep; 36(6):503-9. PubMed ID: 16007103
[TBL] [Abstract][Full Text] [Related]
3. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
[TBL] [Abstract][Full Text] [Related]
4. Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients.
Gilbert C; Roy J; Belanger R; Delage R; Beliveau C; Demers C; Boivin G
Antimicrob Agents Chemother; 2001 Dec; 45(12):3669-71. PubMed ID: 11709367
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].
Gondo H
Rinsho Ketsueki; 2003 Dec; 44(12):1154-60. PubMed ID: 14978931
[No Abstract] [Full Text] [Related]
6. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature.
Egli A; Bergamin O; Müllhaupt B; Seebach JD; Mueller NJ; Hirsch HH
Transpl Infect Dis; 2008 Feb; 10(1):27-43. PubMed ID: 18086275
[TBL] [Abstract][Full Text] [Related]
9. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group.
Koehl U; Dirkwinkel E; Koenig M; Erben S; Soerensen J; Bader P; Doerr HW; Preiser W; Weissinger E; Klingebiel T; Martin H; Lehrnbecher T
Klin Padiatr; 2008; 220(6):348-52. PubMed ID: 18949669
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
[TBL] [Abstract][Full Text] [Related]
12. In vitro studies of the impact of maribavir on CMV-specific cellular immune responses.
Stachel D; Stevens-Ayers T; Boeckh M
J Clin Virol; 2016 Feb; 75():53-9. PubMed ID: 26780109
[TBL] [Abstract][Full Text] [Related]
13. The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients.
Ozaki KS; Câmara NO; Nogueira E; Pereira MG; Granato C; Melaragno C; Camargo LF; Pacheco-Silva A
Clin Transplant; 2007; 21(5):675-80. PubMed ID: 17845644
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation.
Gerna G; Lilleri D; Callegaro A; Goglio A; Cortese S; Stroppa P; Torre G
Transplantation; 2008 Jul; 86(1):163-6. PubMed ID: 18622294
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
[TBL] [Abstract][Full Text] [Related]
16. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
[TBL] [Abstract][Full Text] [Related]
17. Preemptive therapy for cytomegalovirus infections and the development of resistance to ganciclovir.
Kroes AC; Kalpoe JS
J Infect Dis; 2002 Sep; 186(5):724-5; author reply 725-6. PubMed ID: 12195366
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of foscarnet for preemptive therapy against cytomegalovirus reactivation after unrelated cord blood transplantation.
Takami A; Mochizuki K; Ito S; Sugimori C; Yamashita T; Asakura H; Okumura H; Nakao S
Transplant Proc; 2007; 39(1):237-9. PubMed ID: 17275512
[TBL] [Abstract][Full Text] [Related]
19. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
[TBL] [Abstract][Full Text] [Related]
20. T-cell activation response to allogeneic CMV-infected endothelial cells is not prevented by ganciclovir or foscarnet: implications for transplant vascular sclerosis.
Waldman WJ; LeClaire JD; Knight DA
Transplantation; 2002 Jan; 73(2):314-8. PubMed ID: 11821754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
